Analyst Reni Benjamin works at JMP and is focused on the Healthcare sector with 127 price targets and ratings documented since 2016 spanning on 15 stocks. Analyst's average stock valuation to be materialised ratio is 36.39% with an average time for price targets to be met of 69.64 days.
Most recent stock forecast was given on BCYC, Bicycle Therapeutics plc at 09-Nov-2022.
Reni Benjamin best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 3/2/2022. The price target of $5 was fulfilled within 23 days with a profit of $1.63 (48.37%) receiving and performance score of 21.03.
Average potential price target upside